https://www.factorxi.com/
Factor XIa (FXIa) Is a Promising New Target for Thromboembolic Disease
Learn about a promising new target in cardiovascular and thromboembolic diseases that may help address current unmet needs.
factor xia
https://www.rcsb.org/structure/6VLV
RCSB PDB - 6VLV: Factor XIa in complex with compound 11
Factor XIa in complex with compound 11
rcsb pdbfactor xiacomplexcompound11
https://pmc.ncbi.nlm.nih.gov/articles/PMC11725973/
A Systematic Review of Safety and Efficacy of Factor XI/XIa Inhibitors in Patients With ESKD on...
Factor XI/XIa (FXI/XIa) has emerged as a potential target for antithrombotic therapy, driven by preclinical evidence showing the role of FXI/XIa inhibition for...
https://www.jnj.com/media-center/press-releases/late-breaking-phase-2-data-for-investigational-oral-factor-xia-inhibitor-milvexian-suggest-favorable-antithrombotic-profile-across-a-wide-range-of-doses
Late-Breaking Phase 2 Data for Investigational Oral Factor XIa Inhibitor Milvexian Suggest...
May 7, 2025 - Milvexian demonstrated efficacy and no increase in bleeding across doses with no major bleeds in the milvexian arms, when compared with enoxaparin, for...